SS-31 (ELAMIPRETIDE)

Researchers investigating cellular aging and mitochondrial diseases have focused considerable attention on this synthetic tetrapeptide that specifically homes in on damaged mitochondria. Unlike broader antioxidants that work throughout the cell, SS-31 concentrates its effects where energy production occurs, making it particularly relevant for studies of age-related decline and metabolic disorders. The peptide was originally developed as part of efforts to address conditions where mitochondrial dysfunction plays a central role.

The peptide works by binding directly to cardiolipin, a unique lipid found only in mitochondrial membranes that's essential for proper energy production. When cardiolipin becomes oxidized or damaged—common in aging and disease—the cellular powerhouses become less efficient and produce harmful byproducts. SS-31 essentially acts as a molecular chaperone, helping restore normal electron flow through the energy-producing machinery while mopping up the reactive oxygen species that would otherwise cause further damage.